Spectrum of mutations in RARS-T patients includes TET2 and ASXL1 mutations

被引:33
作者
Szpurka, Hadrian [1 ]
Jankowska, Anna M. [1 ]
Makishima, Hideki [1 ]
Bodo, Juraj [2 ]
Bejanyan, Nelli [1 ]
Hsi, Eric D. [2 ]
Sekeres, Mikkael A.
Maciejewski, Jaroslaw P. [1 ]
机构
[1] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44195 USA
[2] Cleveland Clin, Taussig Canc Inst, Dept Clin Pathol, Cleveland, OH 44195 USA
关键词
RARS-T; TET2; ASXL1; JAK2; V617F; MPLW515L; STAT5; JAK2 V617F MUTATION; ACUTE MYELOID-LEUKEMIA; RINGED SIDEROBLASTS; REFRACTORY-ANEMIA; ESSENTIAL THROMBOCYTHEMIA; MARKED THROMBOCYTOSIS; MYELOPROLIFERATIVE NEOPLASMS; MYELODYSPLASTIC SYNDROMES; UNIPARENTAL DISOMY; POLYCYTHEMIA-VERA;
D O I
10.1016/j.leukres.2010.02.033
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
While a majority of patients with refractory anemia with ring sideroblasts and thrombocytosis harbor JAK2V617F and rarely MPLW515L, JAK2/MPL-negative cases constitute a diagnostic problem. 23 RARS-T cases were investigated applying immunohistochemical phospho-STAT5, sequencing and SNP-A-based karyotyping. Based on the association of TET2/ASXL1 mutations with MDS/MPN we studied molecular pattern of these genes. Two patients harbored ASXL1 and another 2 TET2 mutations. Phospho-STAT5 activation was present in one mutated TET2 and ASXL1 case. JAK2V617F/MPLW515L mutations were absent in TET2/ASXL1 mutants, indicating that similar clinical phenotype can be produced by various MPN-associated mutations and that additional unifying lesions may be present in RARS-T. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:969 / 973
页数:5
相关论文
共 30 条
[1]   Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies [J].
Abdel-Wahab, Omar ;
Mullally, Ann ;
Hedvat, Cyrus ;
Garcia-Manero, Guillermo ;
Patel, Jay ;
Wadleigh, Martha ;
Malinge, Sebastien ;
Yao, JinJuan ;
Kilpivaara, Outi ;
Bhat, Rukhmi ;
Huberman, Kety ;
Thomas, Sabrena ;
Dolgalev, Igor ;
Heguy, Adriana ;
Paietta, Elisabeth ;
Le Beau, Michelle M. ;
Beran, Miloslav ;
Tallman, Martin S. ;
Ebert, Benjamin L. ;
Kantarjian, Hagop M. ;
Stone, Richard M. ;
Gilliland, D. Gary ;
Crispino, John D. ;
Levine, Ross L. .
BLOOD, 2009, 114 (01) :144-147
[2]   The JAK2-V617F mutation and essential thrombocythemia features in a subset of patients with refractory anemia with ring sideroblasts (RARS) [J].
Boissinot, Marjorie ;
Garand, Richard ;
Hamidou, Mohamed ;
Hermouet, Sylvie .
BLOOD, 2006, 108 (05) :1781-1782
[3]   Mutations of ASXL1 gene in myeloproliferative neoplasms [J].
Carbuccia, N. ;
Murati, A. ;
Trouplin, V. ;
Brecqueville, M. ;
Adelaide, J. ;
Rey, J. ;
Vainchenker, W. ;
Bernard, O. A. ;
Chaffanet, M. ;
Vey, N. ;
Birnbaum, D. ;
Mozziconacci, M. J. .
LEUKEMIA, 2009, 23 (11) :2183-2186
[4]   The JAK2 V617F mutation is rare in RARS but common in RARS-T [J].
Ceesay, M. M. ;
Lea, N. C. ;
Ingram, W. ;
Westwood, N. B. ;
Gaken, J. ;
Mohamedali, A. ;
Cervera, J. ;
Germing, U. ;
Gallermann, N. ;
Giagounidis, A. ;
Garcia-Casado, Z. ;
Sanz, G. ;
Mufti, G. J. .
LEUKEMIA, 2006, 20 (11) :2060-2061
[5]   Mutation in TET2 in Myeloid Cancers [J].
Delhommeau, Francois ;
Dupont, Sabrina ;
Della Valle, Veronique ;
James, Chloe ;
Trannoy, Severine ;
Masse, Aline ;
Kosmider, Olivier ;
Le Couedic, Jean-Pierre ;
Robert, Fabienne ;
Alberdi, Antonio ;
Lecluse, Yann ;
Plo, Isabelle ;
Dreyfus, Francois J. ;
Marzac, Christophe ;
Casadevall, Nicole ;
Lacombe, Catherine ;
Romana, Serge P. ;
Dessen, Philippe ;
Soulier, Jean ;
Viguie, Franck ;
Fontenay, Michaela ;
Vainchenker, William ;
Bernard, Olivier A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (22) :2289-2301
[6]  
FLACH J, 2009, HAEMATOLOGICA NOV
[7]   High frequency of the JAK2 V617F mutation in patients with thrombocytosis (platelet count > 600 x 109/L) and ringed sideroblasts more than 15% considered as MDS/MPD, unclassifiable [J].
Gattermann, Norbert ;
Billiet, Johan ;
Kronenwett, Ralf ;
Zipperer, Esther ;
Germing, Ulrich ;
Nollet, Friedel ;
Criel, Arnold ;
Selleslag, Dominik .
BLOOD, 2007, 109 (03) :1334-1335
[8]   Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia [J].
Gelsi-Boyer, Veronique ;
Trouplin, Virginie ;
Adelaide, Jose ;
Bonansea, Julien ;
Cervera, Nathalie ;
Carbuccia, Nadine ;
Lagarde, Arnaud ;
Prebet, Thomas ;
Nezri, Meyer ;
Sainty, Danielle ;
Olschwang, Sylviane ;
Xerri, Luc ;
Chaffanet, Max ;
Mozziconacci, Marie-Joelle ;
Vey, Norbert ;
Birnbaum, Daniel .
BRITISH JOURNAL OF HAEMATOLOGY, 2009, 145 (06) :788-800
[9]   SNP Array Karyotyping Allows for the Detection of Uniparental Disomy and Cryptic Chromosomal Abnormalities in MDS/MPD-U and MPD [J].
Gondek, Lukasz P. ;
Dunbar, Andrew J. ;
Szpurka, Hadrian ;
McDevitt, Michael A. ;
Maciejewski, Jaroslaw P. .
PLOS ONE, 2007, 2 (11)
[10]   Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms [J].
Jankowska, Anna M. ;
Szpurka, Hadrian ;
Tiu, Ramon V. ;
Makishima, Hideki ;
Afable, Manuel ;
Huh, Jungwon ;
O'Keefe, Christine L. ;
Ganetzky, Rebecca ;
McDevitt, Michael A. ;
Maciejewski, Jaroslaw P. .
BLOOD, 2009, 113 (25) :6403-6410